Jiazhi Chen

Prof. Dr. Jiazhi Chen


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2020 in Bioresource Technology
Verified
Journal Article
Closed access
YLYuan Li
Yuan Li
FWFei Wang
Fei Wang
YMYaowen Miao
Yaowen Miao
YMYuliang Mai
Yuliang Mai
HLHuanling Li
Huanling Li
JCJiazhi Chen
Jiazhi Chen

13 March 2023 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
GZGuozhi Zhu
Guozhi Zhu
DYDawei Ye
Dawei Ye
XCXiaotian Chen
Xiaotian Chen
YWYuchao Wu
Yuchao Wu
ZYZongmei Yang
Zongmei Yang
JCJiazhi Chen
Jiazhi Chen

30 October 2024 in Ceramics International
Verified
Journal Article
Closed access
JJJian Ji
Jian Ji
DYDawei Ye
Dawei Ye
YZYuming Zhong
Yuming Zhong
YMYuliang Mai
Yuliang Mai
JCJiazhi Chen
Jiazhi Chen

23 March 2024 in Journal of Orthopaedic Translation
Verified
Journal Article
Open access
GWGang Wang
Gang Wang
CMChao Ma
Chao Ma
LMLiang Mo
Liang Mo
JCJiazhi Chen
Jiazhi Chen
JYJinbo Yuan
Jinbo Yuan
WHWei He
Wei He
Glucocorticoid-induced osteonecrosis of the femoral head (GIONFH) is a common bone and joint disease. There is currently a lack of effective treatment for GIONFH, and the disease progression may lead to total hip arthroplasty (THA). The exact mechanism of GIONFH pathogenesis remains unsettled, and emerging evidence indicates that the overactivation of osteoclasts plays a pivotal role in the occurrence and progression of this condition. Our previous study has shown that cycloastragenol (CAG), a triterpenoid saponin with multiple bioactivities, is a natural osteoclast inhibitor and has a protective effect on bone loss. However, its effect on GIONFH remains unclear. In this study, methylprednisolone (MPS) (20 mg/kg) was administered via gluteal muscle injection to female Sprague–Dawley (SD) rats to induce GIONFH, and different doses of CAG (5 and 15 mg/kg) were dispensed intraperitoneally for intervention. Micro-CT screening and angiography were applied to determine the shaping of necrotic lesions, the loss of trabecular bone, and the change in the local blood supply. The molecular mechanism was established by Real-time qPCR and Western blotting. Hematoxylin and eosin (H&E) staining was performed to identify empty lacunae in the femoral head. CAG treatment shanked the necrotic lesion area, inhibited the trabecular bone loss, and improved the local blood supply in the femoral head. In addition, CAG medication lowered the ratio of Tnfsf11 (encoding RANKL) to Tnfrsf11b (encoding OPG) and the expression of osteoclast-specific genes, including Acp5 and Ctsk. Consistently, CAG treatment exhibited a dose-dependent weakening effect on the expression of osteoclastogenesis and bone resorption-related proteins, including TRAP, CTSK, and MMP9. CAG addition also alleviated the occurrence of empty lacunae in the subchondral region. Our discoveries demonstrate that CAG is a potential option for hip preservation therapy in GIONFH patients. The protective effect of CAG on rats with GIONFH can be translated into clinical use.

25 June 2019 in Journal of Surfactants and Detergents
Verified
Journal Article
Closed access
PDF file
JCJiazhi Chen
Jiazhi Chen
YLYuan Li
Yuan Li
XCXiaotian Chen
Xiaotian Chen
YMYuliang Mai
Yuliang Mai
MGMinjie Gao
Minjie Gao
XWXi Wang
Xi Wang

7 February 2024 in RSC Advances
Verified
Journal Article
Open access
PDF file
GZGuozhi Zhu
Guozhi Zhu
HXHongmei Xie
Hongmei Xie
DYDawei Ye
Dawei Ye
JZJunjie Zhang
Junjie Zhang
KHKangping Huang
Kangping Huang
JCJiazhi Chen
Jiazhi Chen
A heterogeneous oxidative process is reported towards sustainable production of valuable catechol derivatives from the depolymerization of Tung nutshell C/G lignin by Cu–NC catalytic process. The CuO and Cu 2 O might be active species for oxidation.